K. Lammertsma et al.
(s); HR-MS calcd for C17H27MoN2O5P: 457.9929; found 457.99393 (d 1
10ꢀ3); IR(CH2Cl2): n˜ =2072 (w) (n(CO)), 1944 cmꢀ1 (s) (n(CO)).
592.00659 (d 110ꢀ3); IR (CH2Cl2): n˜ =2025 (m) (n(CO)), 1913 cmꢀ1 (s)
(n(CO)).
ACHTREUNG
Synthesis
phosphabicyclo
of
cis-tetracarbonyl(dimethyl
5,6-dimethyl-7-phenyl-7-
Synthesis of 13 by irradiation of 25 in the presence of phenylphosphole:
A solution of complex 25 (1.55 g, 3.4 mmol) and 3,4-dimethyl-1-phenyl-
phosphole (637 mg, 3.4 mmol) in THF (100 mL) was prepared. This mix-
ture was irradiated for 5 h with light from a high-pressure Philips Hg
lamp (0.9 A, Type 93110E), while N2 was bubbled through the solution at
a slow rate. Evaporation of THF and subsequent column chromatography
starting with pentane and gradually changing to pentane/dichlorome-
thane (4:1) resulted in the isolation of complex 13 (580 mg, 28%) as a
yellow solid. Furthermore, compound 25 (700 mg, 45%) was recovered
and could be re-used. The yields are calculated based on the amount of
starting material used (3.4 mmol) and are not corrected for recovery of
25. Recrystallization of 13 from DCM/hexane gave yellow crystals. M.p.
142–1438C; 1H NMR (CDCl3): d=2.07 (s, 6H; phosphole-CH3), 2.92 (d,
3JP, H =14.1 Hz, 6H; NCH3), 3.11–3.25 (m, 2H; CH2N), 4.14–4.23 (m, 2H;
CH2N), 6.00 (m, 2H; phosphepine HC=), 6.40 (d, 2JP, H =35.3 Hz, 2H;
AHCTREUNG
tetrahydro-1H-phosphepine)molybdenum (15): A mixture of complex 12
(0.500 g, 0.85 mmol) and dimethylacetylene dicarboxylate (2.5 mL,
20 mmol) was stirred at 508C for 22 h. Column chromatography over
silica gel, starting with pentane as eluent and gradually changing to di-
chloromethane, gave recovered dimethylacetylene dicarboxylate first, fol-
lowed by compound 15 (390 mg, 63%) as a yellow oil. Crystallization
from dichloromethane/hexane gave yellow crystals. M.p. 131–1328C;
1H NMR (CDCl3): d=1.88 (d, 4JP, H =0.9 Hz, 6H; CH3), 2.19–2.35 (m,
8H; CH2-P & CH2), 3.39 (d, 2JP, H =2.9 Hz, 2H; phosphanorbornadiene-
CH), 3.61 (s, 6H; OCH3), 5.73 (m, 2H; =CH), 7.26–7.49 ppm (m, 10H;
Ar); 13C NMR (CDCl3): d=16.2 (d, 3JP, C =1.8 Hz; CH3), 23.3 (d, JP,C
=
2
5.2 Hz; CH2C=), 29.2 (dd, 3JP, C =1.8, 1JP, C =19.9 Hz; CH2P), 52.4 (s,
OCH3), 60.0 (dd, 3JP, C =2.0, 1JP, C =14.3 Hz; phosphonorbornadiene-CH),
128.1–130.4 (m; Ar), 131.7 (s; =CH), 137.7 (d, 1JP,C =17.4 Hz; phospha-
phosphole HC=), 7.26–7.60 ppm (m, 10H; Ar); 13C NMR (CDCl3): d=
3
1
2
17.6 (d, 3JP,C =10.1 Hz; phosphole-CH3), 40.0 (dd, 4JP,C =2.0, JP,C
=
norbornadiene ipso-Ph), 139.3 (dd, JP,C =2.4, JP, C =27.4 Hz; phosphepine
ipso-Ph), 142.3 (d, 2JP,C =3.0 Hz; CHCCH3), 146.2 (d, 2JP, C =3.5 Hz;
2
15.0 Hz; NCH3), 49.0 (d, JP, C =6.8 Hz; CH2N), 128.7–131.6 (m, Ar), 131.3
(dd, 3JP, C =11.6, 1JP, C =46.7 Hz; phosphole-CH), 133.4 (d, 1JP,C =32.2 Hz;
phosphole ipso-Ph), 134.6 (s; phosphepine-CH), 141.7 (d, 1JP, C =55.7 Hz;
CCO2CH3), 165.6 (d, 3JP, C =2.3 Hz; CO2CH3), 209.3 (dd, 2JP, C =8.0, JP,C
=
2
9.8 Hz; COax), 214.8 (dd, 2JP, C =8.8, 2JP,C =12.4 Hz; COeq), 215.3 ppm (dd,
2JP, C =5.7, 2JP, C =8.8 Hz; COeq); 31P NMR (CDCl3): d=25.7 (d, JP, P
=
2
phosphepine ipso-Ph), 148.7 (d, 2JP, C =8.11 Hz; P CH=C), 209.3 (dd,
ꢀ
26.1 Hz; phosphepine), 251.9 ppm (d, 2JP, P =26.1 Hz; phosphanorborna-
diene-P); IR (CH2Cl2): n˜ =2021 (m) (n(CO)), 1915 (s) (n(CO)),
1890 cmꢀ1 (sh) (n(CO)). Compound 15 was too unstable for HR-MS; for-
mation of 18 was observed.
2JP, C =8.5, 2JP, C =10.3 Hz; COax), 215.0 (dd, 2JP, C =9.8, 2JP, C =21.1 Hz;
COeq), 216.2 ppm (dd, 2JP,C =8.6, 2JP,C =30.4 Hz; COeq); 31P NMR
2
(CDCl3): d=32.3 (d, 2JP, P =25.5 Hz; phosphole), 138.2 ppm (d, JP, P
=
25.5 Hz; phosphepine); HR-MS calcd for C28H30MoN2O4P2: 618.0735;
found 618.07009 (d 210ꢀ3); IR
(CH2Cl2): n˜ =2022 (m) (n(CO)), 1908 (s)
(n(CO)), 1875 cmꢀ1 (sh) (n(CO)).
Synthesis of tetracarbonyl(3,4-dimethyl-1-phenyl-1H-phosphole)(2-
A
Synthesis
phosphabicyclo
of
cis-tetracarbonyl(dimethyl
5,6-dimethyl-7-phenyl-7-
AHCTREUNG
phenyl-2,3,4,7-tetrahydro-1H-[1,3,2]diazaphosphepine)molybdenum (16):
A solution of complex 13 (500 mg, 0.81 mmol) and dimethylacetylene di-
carboxylate (3 mL; 24 mmol) in dichloromethane (1 mL) was heated for
28 h at 458C. Column chromatography, starting with hexane and gradual-
ly changing to dichloromethane as eluent, afforded complex 16 (330 mg;
55%) as an orange solid. Recrystallization (CH2Cl2/hexane) resulted in
the formation of orange needles. M.p. 71–728C; 1H NMR (CDCl3): d=
1.96 (d, 4JP,H =1.0 Hz, 6H; CH3), 2.96 (d, 3JP, H =14.1 Hz, 6H; NCH3),
3.13–3.20 (m, 2H; CH2N), 3.59 (s, 2H; phosphanorbornadiene-CH), 3.61
phenyl-4,7-dihydro-[1,3,2]dioxaphosphepine)molybdenum (14)
Synthesis of 2-phenyl-4,7-dihydro-1,3,2-dioxaphosphepine (7): PhPCl2
(3.58 g, 20.0 mmol) in 50 mL of diethyl ether was slowly added to a solu-
tion of triethylamine (4.55 g, 40.0 mmol) and cis-but-2-ene-1,4-diol
(1.84 g, 20.0 mmol) in 150 mL of diethyl ether at 08C and stirred for 1 h
before warming to room temperature. 31P NMR spectroscopy showed an
excellent conversion to the desired product. After filtration of the salts
and evaporation of solvent, 3.00 g of 7 (>90% pure by 31P NMR) was
obtained as a colorless oil, which could be used without further purifica-
tion. A minor side product (<10% by 31P NMR) at d=21.6 ppm was ob-
served. During distillation, a gummy material was formed that reduced
the yield dramatically. After distillation at 808C/210ꢀ4 mbar, 7 (830 mg;
24%) was obtained as an air-sensitive colorless oil.
(s, 6H; OCH3), 4.16–4.20 (m, 2H; CH2N), 6.00 (m, 2H; phosphepine-
CH), 7.04–7.49 ppm (m, 10H; Ar); 13C NMR (CDCl3): d=16.2 (d, JP, C
=
3
2.1 Hz; CH3), 40.0 (d, 2JP, C =14.1 Hz; NCH3), 49.0 (d, 2JP, C =6.9 Hz;
CH2N), 52.3 (s, OCH3), 60.5 (dd, 3JP,C =1.4, 1JP,C =14.2 Hz; phosphonor-
1
bornadiene-CH), 127.9–131.2 (m; Ar), 134.7 (s; =CH), 138.1 (d, JP,C
=
17.4 Hz; phosphanorbornadiene ipso-Ph), 141.7 (dd, 3JP,C =1.5, JP,C
=
1
2
1H NMR (CDCl3): d=4.45–4.66 (m, 4H; CH2), 5.75 (t, H,H =1.9 Hz, 2H;
57.0 Hz; phosphepine ipso-Ph), 141.9 (d, 2JP, C =2.8 Hz; CHCCH3), 146.7
CH2CH), 7.44–7.48 (m; 3H; Ar), 7.68–7.74 ppm (m; 2H; Ar); 13C NMR
2
3
(d, JP,C =3.6 Hz; CCO2CH3), 165.7 (d, JP, C =2.1 Hz; CO2CH3), 208.9 (dd,
2JP, C =8.2, 2JP, C =10.5 Hz; COax), 215.0 (dd, 2JP, C =10.8, 2JP, C =28.9 Hz;
COeq), 215.8 ppm (dd, 2JP,C =10.0, 2JP,C =28.2 Hz; COeq); 31P NMR
(CDCl3): d=250.5 (d, 2JP, P =26.6 Hz; 7-phosphanorbornadiene),
137.6 ppm (d, 2JP, P =26.6 Hz; phosphepine); IR (CH2Cl2): n˜ =2024 (m)
(n(CO)), 1918 (s) (n(CO)), 1889 cmꢀ1 (sh) (n(CO)). Compound 16 was
too unstable for HR-MS; formation of compound 19 was observed.
4
3
(CDCl3): d=64.0 (s; CH2), 128.2 (d, JP, C =4.9 Hz; m-Ph), 129.6 (d, JP, C
=
20.6 Hz; o-Ph), 130.0 (s; phosphepine HC=), 131.3 (s; p-Ph), 140.8 ppm
1
(d, JP, C =32.0 Hz; ipso-Ph); 31P NMR (CDCl3): d=161.1 ppm (s).
Synthesis of 14:
A mixture of cis-[Mo(CO)4(piperidine)2](2.1 g,
5.6 mmol) and 2-phenyl-4,7-dihydro-1,3,2-dioxaphosphepine (7; 1.1 g,
5.6 mmol) was stirred in refluxing dichloromethane (20 mL) for 10 min.
3,4-Dimethyl-1-phenylphosphole (1.0 g, 5.6 mmol) in dichloromethane
(10 mL) was added and the mixture was stirred at reflux for an additional
3 h. Evaporation to dryness and column chromatography (silica gel; pen-
tane/dichloromethane, 4:1) gave complex 14 (0.841 g; 30%) as a yellow
solid. Recrystallization from diethyl ether/hexane afforded yellow crys-
tals. M.p. 111–1128C; 1H NMR (CDCl3): d=2.05 (s, 6H; CH3), 4.41–4.62
(m, 4H; CH2), 5.70 (s, 2H; CH, phosphepine), 6.41 (d, 2JP, H =36.3 Hz,
2H; CH phosphole), 7.29–7.54 ppm (m, 10H; Ar); 13C NMR (CDCl3):
Synthesis
phosphabicyclo
of
cis-tetracarbonyl(dimethyl
5,6-dimethyl-7-phenyl-7-
AHCTREUNG
hydro-[1,3,2]dioxaphosphepine)molybdenum (17): A mixture of complex
14 (0.72 g, 1.2 mmol) and dimethylacetylene dicarboxylate (2.5 mL,
20 mmol) was stirred at 458C for 22 h. Column chromatography over
silica gel, starting with pentane as eluent and gradually changing to di-
chloromethane, gave dimethylacetylene dicarboxylate first, followed by
complex 17 (0.61 g; 69%) as a yellow oil. Crystallization from dichloro-
methane/hexane gave yellow crystals. M.p. 139–1408C; 1H NMR
(CDCl3): d=1.97 (d, 4JP, H =0.8 Hz, 6H; CH3), 3.63 (s, 6H; OCH3), 3.77
(d, 2JP, H =2.6 Hz, 2H; phosphanorbornadiene-CH), 4.45–4.56 (m, 4H;
3
d=17.7 (d, JP,C =10.3 Hz; CH3), 64.6 (d, 2JP, C =6.0 Hz; CH2), 128.5–131.5
1
(m; Ph), 129.4 (s; phosphepine HC=), 131.2 (d, JP, C =35.0 Hz; phosphole
1
HC=), 133.8 (d, 1JP, C =33.0 Hz; phosphole ipso-Ph), 141.2 (d, JP,C
=
33.8 Hz; phosphepine ipso-Ph), 148.9 (d, 2JP, C =8.2 Hz; CHCCH3), 209.0
CH2), 5.75 (s, 2H; =CH), 7.09–7.59 ppm (m, 10H; Ar); 13C NMR
2
2
2
2
(CDCl3): d=16.3 (d, 3JP, C =1.8 Hz; CH3), 52.4 (s, OCH3), 60.4 (dd, JP, C
=
3
(dd, JP, C =8.8, JP, C =12.1 Hz; COax), 213.7 (dd, JP, C =11.5, JP,C =19.4 Hz;
COeq), 214.0 ppm (dd, 2JP,C =8.2, 2JP,C =36.6 Hz; COeq); 31P NMR
2.0, 1JP, C =15.4 Hz; phosphonorbornadiene-CH), 64.8 (d, 2JP,C =6.1 Hz;
OCH2), 128.1–129.5 (m; Ar), 131.0 (s; =CH), 138.0 (d, 1JP,C =17.4 Hz;
phosphanorbornadiene ipso-Ph), 141.3 (d, 1JP, C =34.9 Hz; phosphepine
(CDCl3): d=33.0 (d, 2JP, P =29.0 Hz; phosphole-P), 190.9 ppm (d, JP, P
=
2
29.0 Hz; O-P); HR-MS calcd for C26H24MoO6P2: 592.0103; found
4338
ꢀ 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2006, 12, 4333 – 4340